🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
4.310
-0.040 (-0.92%)
Nov 20, 2026, 4:00 PM EST - Market closed

Treace Medical Concepts Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Treace Medical Concepts stock has a consensus rating of "Buy" and an average price target of $6.17. The average 1-year stock price forecast is 43.09% higher than the current stock price, while the lowest is $5.00 (+16.01%) and the highest is $7.00 (+62.41%).

Price Target: $6.17 (+43.09%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$5.00$6.17$6.50$7.00
Change+16.01%+43.09%+50.81%+62.41%

Analyst Ratings

The average analyst rating for Treace Medical Concepts stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingApr '26May '26Jul '26Aug '26Sep '26Nov '26
Strong Buy111112
Buy000000
Hold333332
Sell111111
Strong Sell000000
Total555555

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Stifel Nicolaus
Stifel Nicolaus
Buy
Upgrades
$4.5 → $6.5
BuyUpgrades$4.5 → $6.5+50.81%Nov 9, 2026
Lake Street
Lake Street
Buy
Reiterates
$7
BuyReiterates$7+62.41%Aug 10, 2026
Truist Financial
Truist Financial
Hold
Reiterates
$4 → $5
HoldReiterates$4 → $5+16.01%Aug 10, 2026
UBS
UBS
Hold
Maintains
$2.5 → $2.25
HoldMaintains$2.5 → $2.25-47.80%Mar 2, 2026

Financial Forecast

Revenue This Year
207.81M
from 212.69M
Decreased by -2.29%
Revenue Next Year
220.59M
from 207.81M
Increased by 6.15%
EPS This Year
-0.91
from -0.80
EPS Next Year
-0.85
from -0.91
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026E
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
94.42M141.84M187.12M209.36M212.69M207.81M
Revenue Growth
64.59%50.22%31.92%11.89%1.59%-2.29%
Gross Profit
77.53M116.31M151.94M168.26M169.75M163.65M
Gross Margin
82.11%82.00%81.20%80.37%79.81%78.75%
Operating Income
-16.51M-34.84M-51.43M-55.69M-54.15M-48.10M
Net Income
-20.55M-42.82M-49.53M-55.74M-59.00M-51.81M
EPS
-----0.80-0.91
Free Cash Flow
-----29.49M-12.00M
No. Analysts
-----5
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High208.0M
Avg207.8M
Low207.4M

Revenue Growth

Revenue Growth202620272028
High
-2.2%
Avg
-2.3%
Low
-2.5%

EPS Forecast

EPS202620272028
High-0.91
Avg-0.91
Low-0.91

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-